Meta-learning for medical imaging: where are we after ICML?
Last week took place the renowned International Conference on Machine Learning (ICML) in Long Beach, CA. Kay looked at the status of meta-learning research and what it could mean for medical imaging.read full story »
Theranos - a cautionary tale for medical devices companies
Recently I read Bad Blood by John Carreyrou about the blood-testing start-up Theranos. It describes the terrifying history of this company that imploded in 2018 after this book exposed the manipulation of staff, investors, customers and regulators by founder Elizabeth Holmes.read full story »
This podcast is a must for everyone interested in radiology stories.
Don’t get me wrong, RadCast is far from being just about radiology. Across the first 10 episodes that are currently live, the RadCast crew tells real, human stories from diverse figures of the radiology world.read full story »
On first sight and consideration, one may say that new solutions driven by Artificial Intelligence perfectly align with the current regulation regarding software as a stand-alone medical device. Whilst both the FDA and the European Commission consider the existence of ‘software as a stand-alone medical device’ (or ‘SaMD’), in their regulatory frameworks, do these frameworks still hold when the technology and ability of AI evolves?read full story »
The hype around AI is slowly starting to fade and something a lot more exciting is emerging; the first AI solutions that create value in your clinical practice. There are quite a few events that put Artificial Intelligence in the spotlight. These events, like the UK Sectra Customer meeting or the ESTI-Fleischner Joint Meeting are fantastic opportunities to assess the solutions that fit your team and patient needs. You’ll have the opportunity to hear from vendors like Aidence what is required to implement AI in your hospital.read full story »
Artificial intelligence has the opportunity to cause a huge disruption in the way radiology operates. But data scientists in healthcare are faced with a major challenge: how do we gather enough data to ensure that algorithms work on different patient populations, scanner types, or even reconstruction techniques?
Read how Marysia Winkels, Data Scientist at Aidence, managed to achieve better performance while training our algorithms on 10 times less data using Group-Convolutions.Check Marysia’s blog » read full story »
As Aidence we are proud to announce we have completed a €10 million Series A funding round. The round was led by INKEF Capital and co-investor Rabo Ventures, alongside our existing investors Northzone, HenQ and Health Innovations. This investment brings Aidence’s total funding to €12.5 million.read more »
We are very proud to announce that the results from a recently completed clinical study involving Veye Chest will be showcased at ECR 2019. This clinical study was conducted at the world-renowned Royal Infirmary of Edinburgh hospital (NHS Lothian) and the Edinburgh imaging facility QMRI, under the leadership of Dr. Prof. John Murchison.read more »
Aidence will be present at both the British Institute of Radiology (BIR) annual meeting on the 2nd of November at St. Paul’s, London and the European Society of Medical Imaging Informatics (EUSOMII) annual meeting in the Erasmus Medical Centre, Rotterdam on the 3rd of November.
At the BIR annual meeting our business development director Nynke Breimer will be giving a talk on the lessons we have learned from implementing AI in routine clinical practice. At EUSOMII our CEO Mark-Jan Harte will be participating in a startup pitch competition and the Aidence team will be showcasing Veye Chest at our booth. If you’re attending either of these events, do make sure to ask us how Aidence & Veye Chest can empower you to focus on complex cases and patient care.
Aidence has reached a major milestone in medical image analysis with the obtaining of a CE mark level IIa for the latest version of its product Veye Chest. Clinical approval for fully automated pulmonary nodule management is a first in medical imaging. Veye Chest enables radiologists to use Veye Chest for automated detection, characterisation and growth measurement of pulmonary nodules. Several hospitals in Europe are currently in the process of deploying this new version of Veye Chest for use in daily clinical practice.read more »
The first Medical Imaging Deep Learning (MIDL) conference will take place in our home town Amsterdam. Aidence is a sponsor and active participant of this event. Tim Salimans, co-founder and Scientific Advisor of Aidence and Marysia Winkels, data engineer at Aidence are both presenting about the cutting edge Deep Learning we are developing at Aidence.read more »
The Aidence team is proud to announce Dr. Arjun Nair and Dr. Diederik Kingma will join its advisory board. The Advisory Board helps Aidence achieve its mission of creating Deep Learning solutions that have meaningful clinical impact.read more »
Aidence will be exhibiting in the startup street at the SIIM 2018 annual meeting in Gaylord National Resort. We showcase Veye Chest our highly accurate AI assistant that supports with detecting, reporting and tracking of pulmonary nodules.
We invite you to visit our booth to see Veye yourself and meet the Aidence team.
Book an appointment upfront: mail Nynke Breimer
Aidence, a startup developing medical imaging diagnostic software based on deep learning, announces that it has received a Development Award from SBRI Healthcare.read more »
Aidence is excited to be a first time exhibitor at ECR this year. We showcase Veye Chest our highly accurate AI assistant that supports with detecting, reporting and tracking of pulmonary nodules.
At Aidence we believe that AI will truly be accepted in the clinical practice if it is deeply embedded in the reporting workflow. Therefore we are also proud to show you at our booth integrations with both Sectra en Agfa.
We invite you to visit our booth to see Veye yourself and meet the Aidence team. Mark Jan, Jeroen en Nynke will be there to host you and answer your questions.
Book an appointment upfront: mail Nynke Breimer
Aidence, a startup developing medical imaging diagnostic software based on deep learning, announces that it has received CE Mark level 2a regulatory approval for its Veye Chest solution for pulmonary nodule detection on chest CT. Veye Chest is now cleared for clinical use across the EU.read more »